Skip to main content
Fucun Xie on Muck Rack

Fucun Xie

As seen in: Frontiers, JAMA Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Fucun

Contact Fucun, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data

|
By Chunguang Guo, Chen Li, Fucun Xie, Zehang Jiang
| Frontiers
Introduction Recently, cancer immunotherapies, including the immune checkpoint blockade (ICB) (1) and the chimeric antigen receptor (CAR) T cell therapy (2), have achieved notable success in treating various advanced malignancies. Nevertheless, only a subset of cancer patients responds to such treatments (3).
Open in Who Shared Issue with article?

Comparison of Therapy in Advanced Hepatocellular Carcinoma

|
By Fucun Xie
| JAMA Oncology Verified
Comment & Response April 8, 2021 JAMA Oncol. 2021;7(6):940-941. doi:10.1001/jamaoncol.2021.0531 Original Investigation Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma Mohamad Bassam Sonbol, MD; Irbaz Bin Riaz, MD, MS; Syed Arsalan Ahmed Naqvi, MBBS; Daniel R. Almquist, MD; Syeda Mina, MD; Jehad Almasri, MD; Shiv Shah; Diana Almader-Douglas; Pedro Luiz Serrano Uson Junior, MD; Amit Mahipal, MD; Wen Wee, Ma, MD; Zhaohui Jin, MD; Kabir Mody, MD; Jason Starr, MD; Mitesh J.
Open in Who Shared Issue with article?
See all 2 articles